These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Specific cytokine regulators and their therapeutic potentials--an overview. Kashiwagi H; Suzuki H Intern Med; 1992 Nov; 31(11):1245-9. PubMed ID: 1295618 [No Abstract] [Full Text] [Related]
23. [Immunotherapy of severe infectious states]. Offenstadt G; Guidet B; Lazard T Chirurgie; 1992; 118(10):601-6. PubMed ID: 1345691 [TBL] [Abstract][Full Text] [Related]
24. Sepsis criteria, and selection of patients for immunotherapy. Thijs LG Prog Clin Biol Res; 1994; 388():407-15. PubMed ID: 7831372 [No Abstract] [Full Text] [Related]
25. Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group. Fisher CJ; Dhainaut JF; Opal SM; Pribble JP; Balk RA; Slotman GJ; Iberti TJ; Rackow EC; Shapiro MJ; Greenman RL JAMA; 1994 Jun; 271(23):1836-43. PubMed ID: 8196140 [TBL] [Abstract][Full Text] [Related]
26. [Neonatal bacterial infections]. Granati B; Masiero S Pediatr Med Chir; 1986; 8(4):471-4. PubMed ID: 3575121 [TBL] [Abstract][Full Text] [Related]
27. Septic shock. A seven-year survey of 105 surgical patients. Gray N S Afr Med J; 1974 Oct; 48(48):2033-4. PubMed ID: 4439102 [No Abstract] [Full Text] [Related]
28. [Immunotherapy of sepsis and septic shock]. Ivanović D; Gjurasin M; Gasparović V; Radonić R; Kvarantan M; Merkler M Lijec Vjesn; 1995 Jun; 117 Suppl 2():8-11. PubMed ID: 8649167 [TBL] [Abstract][Full Text] [Related]
29. Immunotherapy of sepsis syndrome: a comparison of the available treatments. Fisher CJ; Bellingan G Klin Wochenschr; 1991; 69 Suppl 26():162-7. PubMed ID: 1813714 [TBL] [Abstract][Full Text] [Related]
35. Treatment of septic shock with immunotherapy. Smith AL Pharmacotherapy; 1998; 18(3):565-80. PubMed ID: 9620107 [TBL] [Abstract][Full Text] [Related]
36. [Antagonists in neonatal sepsis]. Mancilla-Ramírez J; Ramírez-Herrera M; Portillo-Gómez L; Gaitán-Meza J; Dinarello CA Bol Med Hosp Infant Mex; 1993 Sep; 50(9):691-3. PubMed ID: 7690571 [No Abstract] [Full Text] [Related]
37. [New therapeutic strategies in severe sepsis and septic shock]. Oddo M; Schaller MD; Calandra T; Liaudet L Rev Med Suisse Romande; 2004 Jun; 124(6):329-32. PubMed ID: 15293439 [TBL] [Abstract][Full Text] [Related]
38. The epidemiology of sepsis in Colombia: a prospective multicenter cohort study in ten university hospitals. Rodríguez F; Barrera L; De La Rosa G; Dennis R; Dueñas C; Granados M; Londoño D; Molina F; Ortiz G; Jaimes F Crit Care Med; 2011 Jul; 39(7):1675-82. PubMed ID: 21685740 [TBL] [Abstract][Full Text] [Related]
39. [Complex correction of intoxication syndrome in sepsis]. Torbinskiĭ AM Klin Khir (1962); 1991; (1):27-30. PubMed ID: 2067224 [TBL] [Abstract][Full Text] [Related]